ArticleNeuropsychopharmacology reports2026

Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case Study.

Sho Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.